Balancing act: improving safety while retaining efficacy in I-O

Immuno-Oncology Insights 2023; 4(7), 273–277

DOI: 10.18609/ioi.2023.39

Published: 8 November 2023
Paolo Antonio Ascierto

Lauren Coyle, Editor, Immuno-Oncology Insights, speaks with Paolo Ascierto, Director of the Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Tumor Institute Fondazione G. Pascale, to discuss development of I-O treatments and emerging strategies, specifically in melanomas, improving the balance safety profiles and treatment-related toxicities.